These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33187498)

  • 1. Hepatitis C core antigen testing to diagnose active hepatitis C infection among haemodialysis patients.
    Wong XZ; Gan CC; Mohamed R; Yahya R; Ganapathy S; Tan SS; Lim SK
    BMC Nephrol; 2020 Nov; 21(1):480. PubMed ID: 33187498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus core antigen as alternative diagnostic algorithm for active hepatitis C virus infection among haemodialysis population: Cost implications.
    Wong XZ; Amirah A; Gan CC; Fatiha S; Maznah D; Yahya R; Ganapathy S; Tan SS; Mohamed R; Lim SK
    Nephrology (Carlton); 2021 May; 26(5):463-470. PubMed ID: 33580732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening haemodialysis patients for hepatitis C in Vietnam: The inconsistency between common hepatitis C virus serological and virological tests.
    Duong MC; McLaws ML
    J Viral Hepat; 2019 Jan; 26(1):25-29. PubMed ID: 30187621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patients.
    Miedouge M; Saune K; Kamar N; Rieu M; Rostaing L; Izopet J
    J Clin Virol; 2010 May; 48(1):18-21. PubMed ID: 20233674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus antigen detection is an appropriate test for screening and early diagnosis of hepatitis C virus infection in at-risk populations and immunocompromised hosts.
    Kumar R; Chan KP; Ekstrom VSM; Wong JCC; Lim KL; Ng WC; Woo SM; Chan KS; Thangaraju S; Kee TYS; Gan SSW; Foo MWY; Oon LLE; Chow WC
    J Med Virol; 2021 Jun; 93(6):3738-3743. PubMed ID: 32797627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.
    van Tilborg M; Al Marzooqi SH; Wong WWL; Maan R; Vermehren J; Maasoumy B; Mazzulli T; Bolotin S; Garber G; Guerra F; Flud CR; Kowgier M; Janssen HL; de Knegt RJ; Pawlotsky JM; Cloherty GA; Duarte-Rojo A; Sarrazin C; Wedemeyer H; Feld JJ
    Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):856-864. PubMed ID: 30274834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of hepatitis C virus core antigen (HCVcAg) assay to identify active HCV infection in hemodialysis and renal transplant patients.
    Ponnuvel S; Fletcher GJ; Anantharam R; Varughese S; David VG; Abraham P
    PLoS One; 2021; 16(4):e0250263. PubMed ID: 33886631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical usefulness of HCV core antigen assay for the management of patients with chronic hepatitis C.
    Florea D; Neaga E; Nicolae I; Maxim D; Popa M; Otelea D
    J Gastrointestin Liver Dis; 2014 Dec; 23(4):393-6. PubMed ID: 25531997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardized prevalence ratios for chronic hepatitis C virus infection among adult Japanese hemodialysis patients.
    Ohsawa M; Kato K; Itai K; Tanno K; Fujishima Y; Konda R; Okayama A; Abe K; Suzuki K; Nakamura M; Onoda T; Kawamura K; Sakata K; Akiba T; Fujioka T
    J Epidemiol; 2010; 20(1):30-9. PubMed ID: 19881229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV Ag quantification as a one-step procedure in diagnosing chronic hepatitis C infection in Cameroon: the ANRS 12336 study.
    Duchesne L; Njouom R; Lissock F; Tamko-Mella GF; Rallier S; Poiteau L; Soulier A; Chevaliez S; Vernet G; Rouveau N; Pawlotsky JM; Girard PM; Lacombe K
    J Int AIDS Soc; 2017 May; 20(1):21446. PubMed ID: 28530032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is hepatitis C virus core antigen an adequate marker for community screening?
    Kuo YH; Chang KC; Wang JH; Tsai PS; Hung SF; Hung CH; Chen CH; Lu SN
    J Clin Microbiol; 2012 Jun; 50(6):1989-93. PubMed ID: 22461676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCV-RNA Pcr Positivity In Hcv Antibody Negative Patients Undergoing Haemodialysis.
    Kiani IG; Khan AN; Butt B; Sabir S; Ejaz S; Perveen A; Ghani E
    J Ayub Med Coll Abbottabad; 2018; 30(3):397-400. PubMed ID: 30465373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection limit of architect hepatitis C core antigen assay in correlation with HCV RNA, and renewed confirmation algorithm for reactive anti-HCV samples.
    Ottiger C; Gygli N; Huber AR
    J Clin Virol; 2013 Nov; 58(3):535-40. PubMed ID: 24041472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection: A Systematic Review and Meta-analysis.
    Freiman JM; Tran TM; Schumacher SG; White LF; Ongarello S; Cohn J; Easterbrook PJ; Linas BP; Denkinger CM
    Ann Intern Med; 2016 Sep; 165(5):345-55. PubMed ID: 27322622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy.
    Veillon P; Payan C; Picchio G; Maniez-Montreuil M; Guntz P; Lunel F
    J Clin Microbiol; 2003 Jul; 41(7):3212-20. PubMed ID: 12843066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus core antigen: A diagnostic and treatment monitoring marker of hepatitis C virus in Indian population.
    Garg J; Verma P; Singh M; Das A; Pathak A; Agarwal J
    Indian J Gastroenterol; 2024 Aug; 43(4):799-804. PubMed ID: 38619807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Dilemmas in Hepatitis C Virus Infection for Hemodialysis Patients.
    Komitova RT; Atanasova MV; Pavlova TA; Nyagolov MS; Ivanova AV
    Folia Med (Plovdiv); 2017 Mar; 59(1):70-77. PubMed ID: 28384106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of enzyme-linked immunosorbent assays to test core antigen in the diagnosis and antiviral therapy management of hepatitis C virus infections.
    Wang L; Chen W; Xi W; Feng J; Dang P; Ma Y; Yu Y
    J Med Virol; 2017 Jul; 89(7):1235-1240. PubMed ID: 27958657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of HCV core antigen ELISA in the screening for hepatitis C virus infection in patients on hemodialysis.
    Reddy AK; Dakshinamurty KV; Lakshmi V
    Indian J Med Microbiol; 2006 Jan; 24(1):55-7. PubMed ID: 16505558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups.
    Yang JF; Lin YY; Hsieh MH; Tsai CH; Liu SF; Yu ML; Dai CY; Huang JF; Lin WY; Lin ZY; Chen SC; Chuang WL
    Kaohsiung J Med Sci; 2011 Jul; 27(7):258-63. PubMed ID: 21757142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.